To determine the direct effect of
estrogen on bone cells, female rats were thyroparathyroidectomized and given either 200 microng of
estradiol cypionate or placebo treatment for 4 to 30 days. After 8 days, an
osteosclerosis of the tibial metaphysis developed in rats treated with
estrogens. Osteoblasts in
estrogen-treated rats were interpreted ultrastructurally to be less active in bone formation than controls. Osteocytes in
estrogen-treated rats were inactive compared to osteocytes in control rats which were continuing the process of bone formation. Osteoclasts were decreased in numbers in rats treated with
estrogen; however, the electron microscopic characteristics of osteoclasts did not differ from controls. These cellular changes were associated with a severe
hypocalcemia in both
estrogen-treated and control rats. Serum
phosphorus and urinary
hydroxyproline were lowered significantly by the administration of
estrogen. It is concluded that metaphyseal
osteosclerosis develops in
estrogen-treated rats independent of
parathyroid hormone and
calcitonin. The osteoclerosis is due to an effect of
estrogens to reduce osteoclast-numbers and a lesser inhibitory effect on the bone-forming activity of osteoblasts and osteocytes. (Am J Pathol 87:311-322, 1977).